Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Day

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Head & Neck|April 19, 2022
Systematic review of neuroendocrine carcinomas of the oropharynxMichael H Froehlich, Michael C Shih, Lindsey Shehee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialEzra E W Cohen, Lisle Nabell, Deborah J Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Head & Neck|April 19, 2022
Systematic review of neuroendocrine carcinomas of the oropharynxMichael H Froehlich, Michael C Shih, Lindsey Shehee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialEzra E W Cohen, Lisle Nabell, Deborah J Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Pageof 3